Santos L, León-Galván MF, Marino-Marmolejo EN

Idioma: Español
Referencias bibliográficas: 68
Paginas: 155-165
Archivo PDF: 160.22 Kb.

RESUMEN

La vía de señalización Notch desempeña un papel fundamental en las diferentes etapas del desarrollo celular como la proliferación, crecimiento, diferenciación y apoptosis. Estudios recientes han demostrado que, dependiendo del nivel de expresión y del contexto celular, los receptores de membrana Notch contribuyen en la resistencia a apoptosis en células tumorales. Estos descubrimientos sugieren que componentes de la vía de señalización Notch son un blanco potencial para el desarrollo de terapias más efectivas contra el cáncer. Esta revisión describe la función de la vía Notch y nuevas estrategias utilizadas en la modulación de su señal.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Morgan, TH. The theory of the gene. Am Nat 1917; 51:513-544.

2. Wu JY, Rao Y. Fringe: Defining borders by regulating the Notch pathway. Curr Opin Neurobiol 1999; 9:537-543.

3. Wharton KA, Johansen KM, Xu T, Artavanis-Tsakonas S. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell 1985; 43:567-581.

4. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: Cell fate control and signal integration in development. Science 1999; 284:770-776.

5. Kidd S, Kelley MR , Young MW. Sequence of the notch locus of Drosophila melanogaster: Relationship of the encoded protein to mammalian clotting and growth factors. Mol Cell Biol 1986; 6:3094-3108.

6. Tamura K, Taniguchi Y, Minoguchi S, Sakai T, Tun T, Honjo T, et al. Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-Jk/Su(H). Curr Biol 1995; 5:1416-1423.

7. Nickoloff BJ, Osborne BA, Miele L. Notch signaling as a therapeutic target in cancer: A new approach to the development of cell fate modifying agents. Oncogene 2003; 22:6598-6608.

8. Radtke F, Raj K. The role of Notch in tumorigenesis: Oncogene or tumour suppressor? Nat Rev Cancer 2003; 3:756-767.

9. Gray GE, Mann RS, Mitsiadis E, Henrique D, Carcangiu ML, Artavanis-Tsakonas S. Human ligands of the Notch receptor. Am J Pathol 1999; 154:785-794.

10. Qi H, Rand MD, Wu X, Sestan N, Wang W, Rakic P, et al. Processing of the notch ligand delta by the metalloprotease Kuzbanian. Science 1999; 283:91-94.

11. Moran JL, Johnston SH, Rauskolb C, Bhalerao J, Bowcock AM, Vogt TF. Genomic structure, mapping, and expression analysis of the mammalian Lunatic, Maniac, and Radical fringe genes. Mamm Genome 1999; 10:535-541.

12. Johnston SH, Rauskolb C, Wilson R, Prabhakaran B, Irvine KD, Vogt TF. A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. Development 1997; 124:

13. 2245-2254.

14. Sundaram M, Greenwald I. Suppressors of a lin-12 hypomorph define genes that interact with both lin-12 and glp-1 in Caenorhabditis elegans. Genetics 1993; 135:765-783.

15. Spana EP, Doe CQ. Numb antagonizes Notch signaling to specify sibling neuron cell fates. Neuron 1996; 17:21-26.

16. Ohtsuka T, Ishibashi M, Gradwohl G, Nakanishi S, Guillemot F, Kageyama R. Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. EMBO J 1999; 18:2196-2207.

17. Kadesch T. Notch signaling: the demise of elegant simplicity. Curr Opin Genet Dev 2004; 14:506-512.

18. Lai EC. Notch signaling: control of cell communication and cell fate. Development 2004; 131:965-973.

19. Bigas A, Martin DIK, Milner LA. Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines. Mol Cell Biol 1998; 18:2324-2333.

20. Uyttendaele H, Ho J, Rossant J, Kitajewski J. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci U S A 2001; 98:5643-5648.

21. Mitsiadis TA, Regaudiat L, Gridley T. Role of the Notch signalling pathway in tooth morphogenesis. Arch Oral Biol 2005; 50:137-140.

22. Fortini ME, Artavanis-Tsakonas S. Notch: Neurogenesis is only part of the picture. Cell 1993; 75:1245-1257.

23. Jan YN, Jan LY. Functional gene cassettes in development. Proc Natl Acad Sci U S A 1993; 90:8305-8317.

24. Greenwald I. Structure/function studies of lin-12/Notch proteins. Review. Curr Opin Genet Dev 1994; 4:556-562.

25. Artavanis-Tsakonas S, Matsuno K, Fortini ME. Notch signaling. Science 1995; 268:225-232.

26. Coffman C, Harris W, Kintner C. Xotch, the Xenopus homolog of Drosophila notch. Science 1990; 249:1438-1441.

27. Bierkamp C, Campos-Ortega JA. A zebrafish homologue of the Drosophila neurogenic gene Notch and its pattern of transcription during early embryogenesis. Mech Dev 1993; 43:87-100.

28. Weinmaster G, Roberts VJ, Lemke G. A homolog of Drosophila Notch expressed during mammalian development. Development 1991; 113:199-205.

29. Lardelli M, Dahlstrand J, Lendahl U. The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium. Mech Dev 1994; 46:123-136.

30. Stifani S, Blaumueller CM, Redhead NJ, Hill RE, Artavanis-Tsakonas S. Human homologs of a Drosophila Enhancer of split gene product define a novel family of nuclear proteins. Nat Genet 1992; 2:119-127.

31. Kopan R, Weintraub H. Mouse notch: Expression in hair follicles correlates with cell fate determination. J Cell Biol 1993; 121:631-641.

32. Horvitz HR, Sternberg PW. Multiple intercellular signalling systems control the development of the Caenorhabditis elegans vulva. Nature 1991; 351:535-541.

33. Reaume AG, Conlon RA, Zirngibl R, Yamaguchi TP, Rossant J. Expression analysis of a Notch homologue in the mouse embryo. Dev Biol 1992; 154:377-387.

34. Benedito R, Duarte A. Expression of Dll4 during mouse embryogenesis suggests multiple developmental roles. Gene Expr Patterns 2005;5:750-755.

35. Baldi A, De Falco M, De Luca L, Cottone G, Paggi MG, Nickoloff BJ, et al. Characterization of tissue specific expression of Notch-1 in human tissues. Biol Cell 2004; 96:303-311.

36. Miele L, Osborne B. Arbiter of differentiation and death: Notch signaling meets apoptosis. J Cell Physiol 1999; 181:393-409.

37. ids=11506867&query_hl=20" Lundkvist J, Lendahl U. Notch and the birth of glial cells. Trends Neurosci 2001; 24:492-504.

38. Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H, et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 2001; 20:3427-3436.

39. Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M, et al. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 2003; 33:416-421.

40. Hasserjian RP, Aster JC, Davi F, Weinberg DS, Sklar J. Modulated expression of notch: 1 during thymocyte development. Blood 1996; 88:970-976.

41. Deftos ML, He YW, Ojala EW, Bevan MJ. Correlating notch: signaling with thymocyte maturation. Immunity 1998; 9: 777-786.

42. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991; 66:649-661.

43. Pear WS, Aster JC. T cell acute lymphoblastic leukemia/lymphoma: A human cancer commonly associated with aberrant Notch 1 signaling. Curr Opin Hematol 2004; 11:426-433.

44. Gridley T. Notch signaling and inherited disease syndromes. Hum Mol Genet 2003; 12:R9-13.

45. Kalimo H, Viitanen M, Amberla K, Juvonen V, Marttila R, Poyhonen M, et al. CADASIL: Hereditary disease of arteries causing brain infarcts and dementia. Neuropathol Appl Neurobiol 1999;25:257-265.

46. Weng AP, Nam Y, Wolfe MS, Pear WS, Griffin JD, Blacklow SC, et al. Growth suppression of Pre-T acute limphoblastic leucemia cells by inhibition of Notch signaling. Mol Cell Biol 2003;23:655-664.

47. Jehn BM, Bielke W, Pear WS, Osborne BA. Cutting edge: Protective effects of Notch-1 on TCR-induced apoptosis. J Immunol 1999; 162:635-638.

48. Young IC, Jeon SH, Jang J, Han S, Kim JK, Chung H, et al. Notch1 confers a resistance to glucocorticoid-induced apoptosis on developing thymocytes by down-regulating SRG3 expression. Proc Natl Acad Sci U S A 2001;98:10267-10272.

49. Capobianco AJ, Zagouras P, Blaumueller CM, Artavanis-Tsakonas S, Bishop JM. Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2. Mol Cell Biol 1997;17:6265-6273.

50. Girard L, Hanna Z, Beaulieu N, Hoemann CD, Simard C, Kozak CA, et al. Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis. Genes Dev 1996;10:1930-1944.

51. Rohn JL, Lauring AS, Linenberger ML, Overbaugh J. Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma. J Virol 1996; 70:8071-8080.

52. Weng AP, Aster JC. Multiple niches for Notch in cancer: Context is everything. Curr Opin Genet Dev 2004;14:48-54.

53. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.

54. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis-Tsakonas S. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci U S A 1995;92:6414-6418.

55. Song LL, Vijaya V, Mascarenhas J, Sanne Weijzen S, Kast WM, Santos L, et al. Endogenous Notch-1 inhibits apoptosis in cervical cancer cells by non-transcriptional activation of NF-kB via the PI3 kinase-AKT pathway. Cancer Res 2005 (sometido).

56. Garcés C, Ruiz-Hidalgo MJ, Font de Mora J, Park C, Miele L, Goldstein J, et al. Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J Biol Chem 1997; 272:29729-29734.

57. Murray KM, Dahl SL. Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis. Ann Pharmacother 1997; 31:1335-1338.

58. Fleming RJ, Yi G, Hukriede NA. Serrate–mediated activation of Notch is specifically blocked by the product of the Fringe gene in the dorsal compartment of the Drosophila wing imaginal disc. Development 1997; 124: 2973-2981.

59. Zlobin A, Jang M, Miele L. Toward the rational design of cell fate modifiers: Notch signaling as a target for novel biopharmaceuticals. Curr Pharm Biotechnol 2000; 1:83-106.

60. Austin CP, Feldman DE, Ida JA Jr, Cepko CL. Vertebrate retinal ganglion cells are selected from competent progenitors by the action of Notch. Development 1995; 121:3637-3650.

61. Shelly LL, Fuchs C, Miele L. Notch inhibits apoptosis in murine erithroleukemia cells and it is necessary for differentiation induced by hybrid polar compounds. J Cell Biochem 1999; 73: 164-175.

62. Li L, Milner LA, Deng Y, Iwata M, Banta A, Graf L, et al. The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity 1998; 8:43-55.

63. Fehon RG, Kooh PJ, Rebay I, Regan CL, Xu T, Muskavitch MA, et al. Molecular interactions between the protein products of the neurogenic loci Notch and Delta, two EGF-homologous genes in Drosophila. Cell 1990; 61:523-534.

64. Mukherjee A, Miele L. Chemical and Structural Approachs to Rational Drug Design. CRC Press 1994: 237-261.

65. Hsieh JJ, Henkel T, Salmon P, Robey E, Peterson MG, Hayward SD. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol Cell Biol 1996; 16:952-959.

66. Boulikas T. Status of gene therapy in 1997: Molecular mechanisms, disease targets, and clinical application. Gene Ther Mol Biol 1998; 1:1-172.

67. Martin F, Boulikas T. The challenge of liposomes in gene therapy. Gene Ther Mol Biol 1998; 1:173-214.

68. Pear WS, Aster JC, Scott ML, Hasserjian RP, Soffer B, Sklar J et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 1996; 183:2283-2291.